熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
康弘藥業(yè) Kanghong Pharmaceuticals
成都康弘藥業(yè)集團(tuán)股份有限公司(以下簡(jiǎn)稱康弘藥業(yè))是一家致力于中成藥、化學(xué)藥及生物制品的研發(fā)、生產(chǎn)、銷售及售后服務(wù)的現(xiàn)代化醫(yī)藥企業(yè)集團(tuán),總部位于四川成都。集團(tuán)成員有:
成都康弘制藥有限公司
四川濟(jì)生堂藥業(yè)有限公司
成都弘達(dá)藥業(yè)有限公司
成都康弘生物科技有限公司
四川康弘醫(yī)藥貿(mào)易有限公司
成都康弘醫(yī)藥貿(mào)易有限公司
四川康弘中藥材種植有限公司
四川康弘合成制藥有限公司
四川濟(jì)生堂中藥飲片有限公司
康弘賽金(成都)藥業(yè)有限公司(中外合資)
現(xiàn)有員工3000余人,擁有中成藥、化學(xué)藥和生物制品生產(chǎn)基地,銷售網(wǎng)絡(luò)遍布全國(guó)31個(gè)省、市、自治區(qū)。
2008年,在中國(guó)化學(xué)制藥工業(yè)協(xié)會(huì)組織的首批全國(guó)制藥企業(yè)信用評(píng)價(jià)中,集團(tuán)成為全國(guó)僅有的七家獲得"AAA級(jí)企業(yè)信用等級(jí)"的制藥企業(yè)之一,集團(tuán)三個(gè)生產(chǎn)基地也在08年同時(shí)榮獲"四川省質(zhì)量信用AAA級(jí)企業(yè)"、"四川省質(zhì)量管理先進(jìn)企業(yè)"榮譽(yù)稱號(hào);2009年,集團(tuán)榮獲中國(guó)醫(yī)藥30年風(fēng)云會(huì)改革開放三十年"創(chuàng)新獎(jiǎng)"。2009年,集團(tuán)商標(biāo)""被認(rèn)定為"中國(guó)馳名商標(biāo)"。
自成立以來(lái),集團(tuán)獲得了各級(jí)政府的關(guān)心指導(dǎo)及社會(huì)各界的廣泛關(guān)注:中共中央政治局常委周永康,全國(guó)人大副委員長(zhǎng)烏云其木格,前國(guó)務(wù)院副總理李嵐清等國(guó)家領(lǐng)導(dǎo)人及省市各級(jí)領(lǐng)導(dǎo)多次蒞臨視察指導(dǎo);美國(guó)貿(mào)易政策及談判顧問委員會(huì)等各國(guó)政、商、學(xué)界代表嘉賓多次來(lái)集團(tuán)考察洽談。
Chengdu Kanghong Pharmaceuticals Group Co., Ltd. is a modern medicinal consortium of nine subsidiaries and a joint-venture company, all located in Chengdu, China. There are over 3000 employees. Kanghong’s core business is to develop, produce and market Traditional Chinese Medicine, small molecule and biologic drugs.
Since the establishment of the Group, the goal of the enterprise, from which the name of the company is derived, has been ‘to contribute to the prosperity of society and the health of the people’. ‘Prosperity’ means to create greater value for the country and people. ‘Health’ means to provide the best medical service and products possible. The consortium companies and staff concentrate all resources to engage in the development, preparation and distribution of medicines in cardiovascular, central nervous system, digestion, respiration, endocrinology and oncology. The Group and its staff strive to be one of the most outstanding pharmaceutical companies in China.
Since the establishment of the Group, it has received wide-spread support from various levels of government, clients and consumers from all walks of life. The Group has received the “Important Enterprise with Advantages” award at provincial and city levels for 5 successive years, and was presented the “Industrial Enterprise with Outstanding Contribution” award in Sichuan province in 2006.